219 related articles for article (PubMed ID: 24281020)
1. Novel mouse models of hepatocarcinogenesis with stepwise accumulation of genetic alterations.
Kim SK; Marusawa H; Eso Y; Chiba T; Kudo M
Dig Dis; 2013; 31(5-6):454-8. PubMed ID: 24281020
[TBL] [Abstract][Full Text] [Related]
2. Expression of activation-induced cytidine deaminase in human hepatocytes during hepatocarcinogenesis.
Kou T; Marusawa H; Kinoshita K; Endo Y; Okazaki IM; Ueda Y; Kodama Y; Haga H; Ikai I; Chiba T
Int J Cancer; 2007 Feb; 120(3):469-76. PubMed ID: 17066440
[TBL] [Abstract][Full Text] [Related]
3. Leptin receptor somatic mutations are frequent in HCV-infected cirrhotic liver and associated with hepatocellular carcinoma.
Ikeda A; Shimizu T; Matsumoto Y; Fujii Y; Eso Y; Inuzuka T; Mizuguchi A; Shimizu K; Hatano E; Uemoto S; Chiba T; Marusawa H
Gastroenterology; 2014 Jan; 146(1):222-32.e35. PubMed ID: 24055508
[TBL] [Abstract][Full Text] [Related]
4. A novel mouse model of hepatocarcinogenesis triggered by AID causing deleterious p53 mutations.
Takai A; Toyoshima T; Uemura M; Kitawaki Y; Marusawa H; Hiai H; Yamada S; Okazaki IM; Honjo T; Chiba T; Kinoshita K
Oncogene; 2009 Jan; 28(4):469-78. PubMed ID: 18997814
[TBL] [Abstract][Full Text] [Related]
5. Activation-induced cytidine deaminase is dispensable for virus-mediated liver and skin tumor development in mouse models.
Nguyen T; Xu J; Chikuma S; Hiai H; Kinoshita K; Moriya K; Koike K; Marcuzzi GP; Pfister H; Honjo T; Kobayashi M
Int Immunol; 2014 Jul; 26(7):397-406. PubMed ID: 24569264
[TBL] [Abstract][Full Text] [Related]
6. Recent advancements in comprehensive genetic analyses for human hepatocellular carcinoma.
Nishida N; Kudo M
Oncology; 2013; 84 Suppl 1():93-7. PubMed ID: 23428866
[TBL] [Abstract][Full Text] [Related]
7. Detection of epigenetic aberrations in the development of hepatocellular carcinoma.
Zhang Y
Methods Mol Biol; 2015; 1238():709-31. PubMed ID: 25421688
[TBL] [Abstract][Full Text] [Related]
8. Activation of hepatic stem cells compartment during hepatocarcinogenesis in a HBsAg HBV-transgenic mouse model.
Anfuso B; El-Khobar KE; Ie SI; Avellini C; Radillo O; Raseni A; Tiribelli C; Sukowati CHC
Sci Rep; 2018 Sep; 8(1):13168. PubMed ID: 30177788
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of liver carcinogenesis in the mdr2-knockout mice.
Katzenellenbogen M; Mizrahi L; Pappo O; Klopstock N; Olam D; Jacob-Hirsch J; Amariglio N; Rechavi G; Domany E; Galun E; Goldenberg D
Mol Cancer Res; 2007 Nov; 5(11):1159-70. PubMed ID: 18025261
[TBL] [Abstract][Full Text] [Related]
10. Proliferating EpCAM-Positive Ductal Cells in the Inflamed Liver Give Rise to Hepatocellular Carcinoma.
Matsumoto T; Takai A; Eso Y; Kinoshita K; Manabe T; Seno H; Chiba T; Marusawa H
Cancer Res; 2017 Nov; 77(22):6131-6143. PubMed ID: 28951464
[TBL] [Abstract][Full Text] [Related]
11. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
Xue KX
Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
[TBL] [Abstract][Full Text] [Related]
12. Genetic basis of hepatitis virus-associated hepatocellular carcinoma: linkage between infection, inflammation, and tumorigenesis.
Takeda H; Takai A; Inuzuka T; Marusawa H
J Gastroenterol; 2017 Jan; 52(1):26-38. PubMed ID: 27714455
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus contributes to hepatocarcinogenesis by modulating metabolic and intracellular signaling pathways.
Koike K
J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S108-11. PubMed ID: 17567457
[TBL] [Abstract][Full Text] [Related]
14. Direct effects of hepatitis B virus-encoded proteins and chronic infection in liver cancer development.
Ringelhan M; Heikenwalder M; Protzer U
Dig Dis; 2013; 31(1):138-51. PubMed ID: 23797136
[TBL] [Abstract][Full Text] [Related]
15. Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice.
Pasquinelli C; Bhavani K; Chisari FV
Cancer Res; 1992 May; 52(10):2823-9. PubMed ID: 1316229
[TBL] [Abstract][Full Text] [Related]
16. Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.
Tornesello ML; Buonaguro L; Tatangelo F; Botti G; Izzo F; Buonaguro FM
Genomics; 2013 Aug; 102(2):74-83. PubMed ID: 23583669
[TBL] [Abstract][Full Text] [Related]
17. Early molecular and genetic determinants of primary liver malignancy.
Feitelson MA; Pan J; Lian Z
Surg Clin North Am; 2004 Apr; 84(2):339-54. PubMed ID: 15062649
[TBL] [Abstract][Full Text] [Related]
18. Human cytidine deaminases facilitate hepatitis B virus evolution and link inflammation and hepatocellular carcinoma.
Deng Y; Du Y; Zhang Q; Han X; Cao G
Cancer Lett; 2014 Feb; 343(2):161-71. PubMed ID: 24120759
[TBL] [Abstract][Full Text] [Related]
19. Two-stage model of chemically induced hepatocellular carcinoma in mouse.
Luo M; Yang F; Huang SX; Kuang ZP; Luo XL; Li YD; Wu JN; Xie YA
Oncol Res; 2013; 20(11):517-28. PubMed ID: 24063282
[TBL] [Abstract][Full Text] [Related]
20. Pathways and gene expression profiles in hepatocellular carcinoma.
Facciorusso A; Nacchiero MC; Rosania R; Laonigro G; Giorgio F; Del Prete V; Panella C; Ierardi E
Minerva Gastroenterol Dietol; 2012 Mar; 58(1):35-48. PubMed ID: 22419003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
